Skip to main content

Table 4 Propensity score analysis for LFS, OS, RI, NRM and cGVHD

From: Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

 

MSD

UD

p value (frailty)

LFS

25.7% (19.1–32.3)

30.1% (23.4–36.8)

0.56

OS

31.3% (24.1–38.6)

38.2% (31.1–45.4)

0.94

RI

54.3% (46.8–61.1)

45.6% (38.3–52.5)

0.11

NRM

20% (14.6–26.1)

24.1% (18.4–30.2)

0.19

cGVHD

24.2% (17.8–31.2)

30.3% (23.4–37.5)

0.08

  1. Abbreviations: cGVHD chronic graft-vs-host disease, LFS leukemia-free survival, MSD matched sibling donor, NRM non-relapse mortality, OS overall survival, UD unrelated donor
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us